X-ray lightsource at DESY identifies promising candidates for COVID drugs
Electron density map of the most antiviral active ingredient calpeptin (yellow) binding at the main protease. © DESY/Sebastian Günther
At DESY's high-brilliance X-ray light source PETRA III, a team from more than 30 research institutions has identified several candidates for active substances against the coronavirus SARS-CoV-2. They bind to an important protein of the virus and could thus be the basis for a drug against Covid-19. The MX team from HZB examined part of the measurement data with special analysis algorithms in order to identify suitable active substances. The study has now been published in the renowned journal Science.
In a so-called X-ray screening, the researchers, under the leadership of DESY, tested almost 6000 known active substances that already exist for the treatment of other diseases in a short amount of time. After measuring about 7000 samples, the team was able to identify a total of 37 substances that bind to the main protease (Mpro) of the SARS-CoV-2 virus, as the scientists report online today in the journal Science. Seven of these substances inhibit the activity of the protein and thus slow down the multiplication of the virus. Two of them do this so promisingly that they are currently under further investigation in preclinical studies. This drug screening – probably the largest of its kind – also revealed a new binding site on the main protease of the virus to which drugs can couple.
“The active substances Calpeptin and Pelitinib clearly showed the highest antivirality with good cell compatibility. Our cooperation partners have therefore already started preclinical investigations with these two substances,” explains DESY researcher Sebastian Günther, first author of the Science publication.
In addition to DESY scientists, researchers from the Universities of Hamburg and Lübeck, the Bernhard Nocht Institute for Tropical Medicine, the Fraunhofer Institute for Translational Medicine and Pharmacology, the Heinrich Pette Institute, the European XFEL, the European Molecular Biology Laboratory EMBL, the Max Planck Society, the Helmholtz-Zentrum Berlin and other institutions are involved in the work.
Note: This is a shortened version of the full text of the press release published at DESY Website.
- BESSY II: Magnetic ‘microflowers’ enhance local magnetic fieldsA flower-shaped structure only a few micrometres in size made of a nickel-iron alloy can concentrate and locally enhance magnetic fields. The size of the effect can be controlled by varying the geometry and number of 'petals'. This magnetic metamaterial developed by Dr Anna Palau's group at the Institut de Ciencia de Materials de Barcelona (ICMAB) in collaboration with her partners of the CHIST-ERA MetaMagIC project, has now been studied at BESSY II in collaboration with Dr Sergio Valencia. Such a device can be used to increase the sensitivity of magnetic sensors, to reduce the energy required for creating local magnetic fields, but also, at the PEEM experimental station, to study samples under much higher magnetic fields than currently possible.
- New material for efficient separation of Deuterium at elevated TemperaturesA novel porous material capable of separating deuterium (D2) from hydrogen (H2) at a temperature of 120 K has been introduced. Notably, this temperature exceeds the liquefaction point of natural gas, thus facilitating large-scale industrial applications. This advancement presents an attractive pathway for the economical production of D2 by leveraging the existing infrastructure of liquefied natural gas (LNG) production pipelines. The research conducted by Ulsan National Institute of Science & Technology (UNIST), Korea, Helmholtz-Zentrum Berlin, Heinz Maier Leibnitz Zentrum (MLZ), and Soongsil University, Korea, has been published in Nature Communications.
- Georg Forster Research Fellow explores photocatalystsDr. Moses Alfred Oladele is working on photocatalysis for CO2 conversion in a joint project with the group of Dr. Matt Mayer, HZB, and Prof. Andreas Taubert at the University of Potsdam. The chemist from Redeemer's University in Ede, Nigeria, came to Berlin in the summer of 2024 with a Georg Forster Research Fellowship from the Alexander von Humboldt Foundation and will work at HZB for two years.